What is the role of elective neck dissection in the management of patients with buccal squamous cell carcinoma and a clinically negative neck?

Buccal squamous cell carcinoma (BSCC) is rare in the United States. Given its location, few anatomical barriers to spread exist and it has been found to have a high loco-regional recurrence rate1,2. The role of the elective neck dissection (END) in the clinically negative neck (N0) is not clear. This study aims to answer the research question: Among patients with N0 BSCC does END improve loco-regional control, distant metastatic rates, and 2 and 5 year survival rates?

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Dsu17V